News

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...
Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.
The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...
Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...
Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...
Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced on ...
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy ...
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' (REGN.O), opens new tab offer for the DNA-testing company ...
A nonprofit controlled by Anne Wojcicki, former chief executive of 23andMe ... 23andMe, which helped popularize at-home DNA test kits and was once valued at $6 billion, declared Chapter 11 ...
Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 ...
yesterday (June 4), 23andMe’s attorney inadvertently revealed that Wojcicki’s post-auction proposal ... to generate consistent revenue beyond its DNA testing kits, which customers typically ...